304 related articles for article (PubMed ID: 29038279)
21. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
23. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
24. A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Watanabe K; Kadota JI
Med Mycol J; 2017; 58(1):E23-E28. PubMed ID: 28250360
[TBL] [Abstract][Full Text] [Related]
25. Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.
Silva DB; Rodrigues LM; Almeida AA; Oliveira KM; Grisolia AB
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):192-9. PubMed ID: 26982177
[TBL] [Abstract][Full Text] [Related]
26. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
27. Limited
Healey KR; Kordalewska M; Jiménez Ortigosa C; Singh A; Berrío I; Chowdhary A; Perlin DS
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082281
[TBL] [Abstract][Full Text] [Related]
28. Rapid Detection of
Hou X; Lee A; Jiménez-Ortigosa C; Kordalewska M; Perlin DS; Zhao Y
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397051
[No Abstract] [Full Text] [Related]
29. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
30. Delineation of the Direct Contribution of Candida auris
Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
[TBL] [Abstract][Full Text] [Related]
31. Pan-azole-resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11.
Moreau J; Noël T; Point K; Tewes F; Deroche L; Clarhaut J; Fitton-Ouhabi V; Perraud E; Marchand S; Buyck JM; Brunet K
Mycoses; 2024 Mar; 67(3):e13704. PubMed ID: 38429226
[TBL] [Abstract][Full Text] [Related]
32. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
33. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
Sanglard D; Ischer F; Parkinson T; Falconer D; Bille J
Antimicrob Agents Chemother; 2003 Aug; 47(8):2404-12. PubMed ID: 12878497
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
[TBL] [Abstract][Full Text] [Related]
37. Azole-Resistant Alleles of
Vu BG; Moye-Rowley WS
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0209821. PubMed ID: 35007132
[TBL] [Abstract][Full Text] [Related]
38. Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis.
Hu T; Wang S; Bing J; Zheng Q; Du H; Li C; Guan Z; Bai FY; Nobile CJ; Chu H; Huang G
Int J Antimicrob Agents; 2023 Dec; 62(6):107010. PubMed ID: 37863341
[TBL] [Abstract][Full Text] [Related]
39. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
Ge SH; Wan Z; Li J; Xu J; Li RY; Bai FY
Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
[TBL] [Abstract][Full Text] [Related]
40. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
